Brandon Harnos, OD
Optometrist · New Paltz, NYNPI 1942856257
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.5%), speaking fees and entertainment — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 42.0% of the total. 2025 is the largest year on record at $3,412, more than ten times the $65 reported in 2019. Among optometrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $69.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$3K
- Alcon$3K
- Amgen$249
- Tarsus Pharmaceuticals, Inc.$212
- Coopervision Inc.$189
- Biotissue Holdings Inc.$146
- plus $577 from 8 others
What the payments were for
- Speaking & faculty fees$3,25048%
- Food & beverage$3,51751%
- Entertainment$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 21 | $2,870 |
| Alcon | 45 | $2,588 |
| Amgen | 2 | $249 |
| Tarsus Pharmaceuticals, Inc. | 6 | $212 |
| Coopervision Inc. | 7 | $189 |
| Biotissue Holdings Inc. | 2 | $146 |
| Kala Pharmaceuticals, Inc. | 2 | $144 |
| Johnson & Johnson Vision Care, Inc. | 3 | $108 |
| Dompe US, Inc. | 1 | $100 |
| Sun Pharmaceutical Industries Inc. | 3 | $72 |
| Optos, Inc. | 1 | $65 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $43 |
| Novartis | 2 | $32 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MIEBO$2,479
- XIIDRA$2,479
- INFUSE$2,352
- BIOTRUE$2,250
- Precision 1$1,000
- DAILIES TOTAL1$1,000
- Air Optix Color$1,000
- TOTAL30$536
- Precision 7$268
- TEPEZZA$249
- Precision7$241
- EYSUVIS$125
- Oxervate$100
How this compares
$6,832 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 42 | $1,032 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 35 | $347 |
Paid to pharmacies, not to this prescriber.
Other optometrist in New Paltz
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.